Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postural changes, dysphagia, and systemic sclerosis

P Barrera1, A A den Broeder, F H van den Hoogen

  • 1Department of Rheumatology, University Hospital Nijmegen, The Netherlands.

Annals of the Rheumatic Diseases
|October 15, 1998
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sarco/endoplasmatic reticulum calcium ATPase activity in healthy muscle and Brody disease.

Biochemistry and biophysics reports·2026
Same author

Oral glucocorticoid premedication for preventing infusion-related reactions to rituximab in rheumatoid arthritis.

Scandinavian journal of rheumatology·2026
Same author

Similar gout flare incidence rates when using once- or twice-daily 0.5 mg colchicine prophylaxis after the start of xanthine oxidase inhibitors.

Scandinavian journal of rheumatology·2025
Same author

Disease Activity Score in 28 joints using C-reactive protein based remission state and still residual swollen joints: theoretically possible, but does it occur in the real world?

Scandinavian journal of rheumatology·2025
Same author

Cost-utility analysis of longstanding exercise therapy versus usual care in people with rheumatoid arthritis and severe functional limitations.

Scandinavian journal of rheumatology·2024
Same author

Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs.

Clinical rheumatology·2024